Cargando…
Virtual and biochemical screening to identify the inhibitors of binding between SARS-CoV-2 spike protein and human angiotensin-converting enzyme 2
Severe acute respiratory syndrome coronavirus (SARS-CoV-2) appeared as a new viral pathogen and caused the COVID-19 pandemic worldwide. Since the antiviral medicines effective for the treatment of COVID-19 are rare, it is necessary to identify the new candidate molecules for chemotherapy. The glycos...
Autores principales: | Park, Chanyoub, Eun, Changsun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045697/ https://www.ncbi.nlm.nih.gov/pubmed/35504156 http://dx.doi.org/10.1016/j.jmgm.2022.108206 |
Ejemplares similares
-
Virtual Screening in Search for a Chemical Probe for Angiotensin-Converting Enzyme 2 (ACE2)
por: Kravets, Iryna O., et al.
Publicado: (2021) -
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020) -
Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020) -
Binding Interactions between Receptor-Binding Domain
of Spike Protein and Human Angiotensin Converting Enzyme-2
in Omicron Variant
por: Jawad, Bahaa, et al.
Publicado: (2022) -
Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)